Telmisartan (40mg), Cilnidipine (10mg),& Metoprolol (ER) 25mg .. .. ... .

TELMISTRUM MT CT 25  
 Telmisartan (40mg), Cilnidipine (10mg),& Metoprolol (ER) 25mg
TELMISTRUM MT CT 25  represents a multifaceted approach to managing hypertension (high blood pressure), particularly in patients who may not achieve target blood pressure levels with monotherapy or dual therapy. TELMISTRUM MT CT 25  
targets different physiological pathways involved in blood pressure regulation, offering a comprehensive strategy to lower blood pressure effectively. Each component of this regimen has a distinct mechanism of action:
Telmisartan
Telmisartan is an Angiotensin II Receptor Blocker (ARB) that works by inhibiting the action of angiotensin II, a powerful vasoconstrictor, thereby relaxing blood vessels and lowering blood pressure. It specifically targets the renin-angiotensin-aldosterone system (RAAS), reducing the workload on the heart and decreasing the risk of cardiovascular events.
Cilnidipine
Cilnidipine is a unique calcium channel blocker (CCB) that blocks both L-type and N-type calcium channels. The blockade of L-type channels leads to vasodilation and lowers blood pressure, while the inhibition of N-type channels reduces the release of norepinephrine and can prevent reflex tachycardia, a common side effect of other vasodilators. This dual action makes Cilnidipine effective in managing blood pressure and potentially beneficial for patients with conditions like renal impairment.
Metoprolol (ER)
Metoprolol ER is an extended-release form of Metoprolol, a selective β1-adrenergic receptor blocker (beta-blocker). It primarily slows down the heart rate and reduces the heart's demand for oxygen, making it highly effective for patients with coronary artery disease, heart failure, or those who have had a heart attack. The extended-release formulation ensures a steady release of the medication over time, providing a consistent therapeutic effect and better patient compliance.
Advantages of TELMISTRUM MT CT 25  

Comprehensive Blood Pressure Control: By targeting different regulatory systems involved in blood pressure control (RAAS, calcium channels, and adrenergic receptors), this combination can effectively lower blood pressure in patients with resistant hypertension.
Reduced Side Effects: Using multiple drugs at lower doses can achieve blood pressure targets while minimizing the risk of side effects associated with higher doses of a single drug.
Improved Compliance: Fewer pills can lead to better adherence to the treatment regimen, although this specific combination may not be available in a single pill.
Considerations and Potential Side Effects
Monitoring: Regular monitoring of blood pressure, kidney function, and electrolyte balance is essential, especially when using multiple antihypertensive agents.
Side Effects: Potential side effects may include dizziness, fatigue, peripheral edema, and bradycardia. The risk of these effects varies with the individual's response to the medication and the doses used.
Patient Selection: TELMISTRUM MT CT 25  
may not be suitable for all patients, including those with certain heart conditions, asthma, or severe peripheral arterial disease. It's crucial to tailor the therapy based on the patient's overall health, comorbidities, and specific needs.
Conclusion
TELMISTRUM MT CT 25  
provides a powerful tool in the management of hypertension, especially for patients whose blood pressure is not adequately controlled with simpler regimens. However, the complexity of this regimen underscores the importance of individualized treatment plans and close monitoring by healthcare professionals to ensure efficacy, minimize side effects, and adjust the therapy as needed to achieve optimal blood pressure control.Steris Healthcare Pvt. Ltd. is a Leading Pharmaceutical Company in India. Established in the year of May 2018. We have 750+ Products & 16+ Super Specialty Segments. Every week we have a new product in our portfolio. In Last 5 years we are dealing in Chronic Therapy and in 4 years we grow by 200% Annually, because we deal in high quality medicine. Steris medicine manufactures at WHO-GMP Approved Plants & We have Legal manufacturing contracts with all leading manufacturers of India. Today we have 1000+ Business Franchise Partners in PAN India. Steris's medicine supply in India's Top or Reputed Hospitals, Pharmacy, Government use or Railway use. Grow with a similar pace with the STERIS. Be first to launch like us.
 For further information please contact:
 info@sterispharma.com  / contact@sterispharma.com 
call/whatsapp: 8209542042, 8955945010,7877551268, 6377716668, 
order now: https://www.sterisonline.com/product/telmistrum-mt-ct-25-133384